Nothing Special   »   [go: up one dir, main page]

Latest News for: phase 2 clinical trial

Edit

Aplagon Announces EUR 7 Million Financing to Advance its APAC Therapeutic for Thrombo-Inflammatory Diseases into Phase 2A Clinical Trials

Pharmiweb 03 Feb 2025
APAC is also poised to complete three ongoing clinical trials; a Phase I clinical trial for Arteriovenous Fistula (AVF) maturation failure, a Phase I intravenous (IV) clinical trial in healthy ...
Edit

MODERNA WAS THE LARGEST INDUSTRY SPONSOR OF CLINICAL TRIALS IN THE UK IN 2023/24 AS CONSTRUCTION ON MODERNA INNOVATION AND TECHNOLOGY CENTRE IN OXFORDSHIRE NEARS COMPLETION

Pharmiweb 03 Feb 2025
Since 2021, Moderna has launched 23 clinical trials across 110 UK sites ... Phase 3 clinical trials for influenza and norovirus, launched in October 2024, have recruited more than 5,000 participants across 70 UK sites.
Edit

Terclara (MOB-015) is now being launched in Norway

Pharmiweb 03 Feb 2025
Moberg Pharma AB (OMX ... "We are proud to now be able to start the launch in Norway ... Phase 3 clinical trials for MOB-015 involving more than 800 patients indicate that the product has the potential to become the future market leader in onychomycosis ... .
Edit

Marginal Zone Lymphoma Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | ...

GetNews 03 Feb 2025
In January 2025, Verismo Therapeutics, a clinical-stage CAR T company specializing in KIR-CAR platform technology, announced the dosing of the first patient in its CELESTIAL-301 Phase 1 clinical trial.
Edit

The Motley Fool: Not-so-bad cinical trial results

The Spokesman-Review 02 Feb 2025
AMGN) started crashing in early November and didn’t improve when the company released data from a phase 2 clinical trial for its weight-loss candidate MariTide ... results to data from clinical trials.
Edit

BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit

Knoxville Daily Sun 01 Feb 2025
Defendants further discussed the potential for a second Phase 2 clinical trial combining azelaprag and semaglutide to treat obesity in individuals ages 18 years and older.
Edit

Cough in Idiopathic Pulmonary Fibrosis Pipeline 2024: Key Developments, Emerging Therapies, and Clinical Trials Detailed ...

GetNews 31 Jan 2025
Emerging Cough in Idiopathic Pulmonary Fibrosis therapies in the different phases of clinical trials are - Orvepitant Maleate, Haduvio (nalbuphine ER), ME-015 (Suplatast Tosilate) BI 1839100, and ...
Edit

Musculoskeletal Pain Pipeline 2024: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | ...

GetNews 31 Jan 2025
Emerging Musculoskeletal Pain therapies in the different phases of clinical trials are- MPC-06-ID, Fasinumab, TLC599, Eli Lilly, AXS-14, Lorecivivint, CNTX-4975, X0002, and others are expected to have ...
Edit

Chronic Rhinosinusitis with Nasal Polyps Pipeline 2024: FDA Approvals and Clinical Trials Landscape with MOA ...

GetNews 31 Jan 2025
Emerging Chronic Rhinosinusitis with Nasal Polyps therapies in the different phases of clinical trials are- NUCALA (mepolizumab), TEZSPIRE (tezepelumab), FASENRA (benralizumab), Tezepelumab, CM310, ...
Edit

Cleveland Clinic Abu Dhabi collaborates with BioTwin

GCC Business News 31 Jan 2025
BioTwin’s partnership with Cleveland Clinic Abu Dhabi aims to validate this cutting-edge technology which is currently in its trial phase by creating unique patient profiles for breast cancer ...
Edit

Chronic Obstructive Pulmonary Market Anticipated to Expand Rapidly During 2024-2034, Says DelveInsight | Genentech, GlaxoSmithKline, ...

GetNews 31 Jan 2025
... patient in its Phase 2a proof-of-concept (“POC”) clinical trial of fexlamose (previously known as “AER-01”) for Chronic Obstructive Pulmonary Disease (“COPD”).
Edit

FDA approves new type of nonopioid painkiller for acute pain

NBC Bay Area 31 Jan 2025
In phase 3 clinical trials by the drugmaker, researchers looked at how well the drug worked after surgery ... Vertex isn’t pursuing the FDA’s approval for suzetrigine to treat chronic pain — a phase ...
Edit

IMCAS 2025: New Galderma Phase Iiib Data Reinforce Rapid Onset And Long-Lasting Aesthetic Improvement With Relabotulinum

MENA FN 31 Jan 2025
(MENAFN - AETOSWire) (BUSINESS WIRE )--Galderma (SWX.GALD), the pure-play dermatology category leader, announced today results from its new phase IIIb RELAX clinical trial demonstrating the rapid ... .
Edit

FDA approves new class of painkiller – the first in more than 20 years

New Atlas 31 Jan 2025
At the beginning of 2024, New Atlas covered the impressive results of Phase 3 clinical trials by Vertex Pharmaceuticals Inc ... Vertex is currently undertaking Phase 3 trials to evaluate suzetrigine’s ...

Most Viewed

×